Clariant today published its Integrated Report 2025, which presents a transparent and concise account of the company's financial and non-financial business activities in 2025.
Clariant today announced fourth quarter 2025 sales of CHF 1.028 billion, representing an increase of 1 % in local currency versus Q4 2024. Pricing was flat, while volumes increased by 1 %.
Clariant has achieved a regulatory milestone with the EU Commission approval based on the EFSA (European Food Safety Authority) positive safety assessment for its renewable rice bran wax additives in food-contact plastics. This authorization, published in the (EU) 2026/245 amending Annex I to Regulation (EU) No 10/2011 on February 2, 2026 positions Clariant's Licocare RBW product line as a sustainable and compliant solution for applications intended to come into contact with food across the European plastics industry.
Clariant today announced that the Board of Directors decided to propose to the AGM on 1 April 2026 the election of Regula Wallimann and Albert Manifold as independent, non-executive members of the Clariant Board.
Clariant today announced that the company received two claims for damages against four companies, including Clariant, from MOL Petrolkémia Zrt. and Slovnaft a.s. (MOL Group), Hungary, and Braskem S.A., Brazil, with the court of Munich, Germany.
